[{"Assets_0_Q2_USD":11230300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":133400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":133600000.0,"StockholdersEquity_0_Q2_USD":5511100000.0,"RevenuesConverted_2_Q2_USD":1991100000.0,"RevenuesConverted_1_Q2_USD":981100000.0,"NetIncomeLossConverted_2_Q2_USD":-19600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":133600000.0,"NetIncomeLossConverted_1_Q2_USD":-57700000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.15,"EarningsPerShareDiluted_1_Q2_USD":-0.43,"EarningsPerShareBasic_2_Q2_USD":-0.15,"EarningsPerShareBasic_1_Q2_USD":-0.43,"CommonStockSharesConverted_0_Q2_shares":133600000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.24,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-82100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":133400000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210811"}]